Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-07

Clinical Trial Update: A Study of Tadalafil in Men With Benign Prostatic Hyperplasia (BPH) and Erectile Dysfunction (ED) [Phase 3]

View source ↗

Summary

Phase 3 trial results evaluating tadalafil in men with benign prostatic hyperplasia and erectile dysfunction. The study is completed and results were posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TADALAFIL (TADALAFIL)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Benign Prostate Hyperplasia, Erectile Dysfunction | Phase 3 | Status: COMPLETED | Results posted: 2017-02-07